St. Ingbert, Germany

Anke Steinbach

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anke Steinbach. Retrieved from https://idiyas.com/inventor/anke-steinbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anke Steinbach: Innovator in Anti-Infective Compounds

Introduction

Anke Steinbach is a notable inventor based in St. Ingbert, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-infective compounds. Her work is characterized by a commitment to innovation and research.

Latest Patents

Anke Steinbach holds 1 patent for her invention related to PQSR modulators. The present invention pertains to compounds according to a general formula, pharmaceutical compositions comprising these compounds, and their use as anti-infectives. This patent highlights her dedication to addressing critical health challenges through innovative solutions.

Career Highlights

Anke is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where she engages in groundbreaking research. Her role at this esteemed institution allows her to collaborate with other experts in the field and contribute to advancements in infection research.

Collaborations

Anke has worked alongside notable colleagues, including Cenbin Lu and Christine K Maurer. These collaborations enhance her research efforts and foster a dynamic environment for innovation.

Conclusion

Anke Steinbach's contributions to the field of pharmaceuticals, particularly through her patent on PQSR modulators, exemplify her role as an innovator in anti-infective research. Her work continues to impact the scientific community and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…